> the reported efficacy would drop by ~30%: instead of 8 confirmed cases in the vax arm vs 162 in the control arm (95.2%), it would become 218 vs. 429 (66.3%).

> the reported efficacy would drop by ~30%: instead of 8 confirmed cases in the vax arm vs 162 in the control arm (95.2%), it would become 218 vs. 429 (66.3%). Not a trivial difference. You know the entire study was done over 44,000 people total, right, not just the < 1000 that Ventavia was responsible for?